Discontinued — last reported Q4 '25
Illumina Americas — Revenue increased by 4.2% to $638.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.3%, from $589.00M to $638.00M. Over 4 years (FY 2021 to FY 2025), Americas — Revenue shows relatively stable performance with a 0.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests growing market share or higher demand for genetic sequencing solutions in the Americas, while a decrease may indicate regional economic headwinds or increased competitive pressure.
This metric represents the total net sales generated from products and services within the Americas geographic region. I...
Comparable to regional revenue reporting by other global life science and biotechnology tool providers.
ilmn_segment_americas_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $589.00M | $583.00M | $625.00M | $648.00M | $639.00M | $597.00M | $594.00M | $616.00M | $640.00M | $663.00M | $601.00M | $603.00M | $640.00M | $609.00M | $589.00M | $570.00M | $586.00M | $612.00M | $638.00M |
| QoQ Change | — | -1.0% | +7.2% | +3.7% | -1.4% | -6.6% | -0.5% | +3.7% | +3.9% | +3.6% | -9.4% | +0.3% | +6.1% | -4.8% | -3.3% | -3.2% | +2.8% | +4.4% | +4.2% |
| YoY Change | — | — | — | — | +8.5% | +2.4% | -5.0% | -4.9% | +0.2% | +11.1% | +1.2% | -2.1% | +0.0% | -8.1% | -2.0% | -5.5% | -8.4% | +0.5% | +8.3% |